Intromedic Signs Agreement with Jeonju City to Develop Healthcare Innovation Platform

[Asia Economy Reporter Hyunseok Yoo] Intromedic announced on the 9th that it has signed a business agreement with Jeonju City to develop a healthcare innovation platform and establish an R&D investment fund.

Jeonju City, Jeonbuk National University, and Intromedic held a signing ceremony at the Jeonbuk National University President's Office on the 9th, stating, "This healthcare innovation platform aligns with the national priority project, the 'Korean New Deal' policy, and we expect it to have a positive effect by contributing to the revitalization of the local economy."

The 'Wellness Life Healthcare Innovation Platform' project will be jointly carried out by Jeonju City, Jeonbuk National University, and Intromedic, and they plan to begin cooperation to raise investment funds for this purpose.

Intromedic is responsible for establishing and operating a private participation fund for Wellness Life Healthcare. It will also participate in the overall project, including the development and operation of a commerce platform for the distribution of products produced by companies participating in the healthcare innovation platform.

Jeonju City promised administrative and policy support for the operation of the innovation platform, and Jeonbuk National University also stated that it will actively participate in R&D and support for research personnel.

Jo Yongseok, CEO of Intromedic, said, "This is a time when investment is needed in new digital healthcare businesses that can lead the untact era," adding, "We will strive to make this project a competitive business model both domestically and internationally."

This content was produced with the assistance of AI translation services.